TrialClinical pharmacology in drug development2019

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended-Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials.

Mohamed-Eslam F Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.